Skip to main content
. 2024 Apr 1;20(7):e445–e452. doi: 10.4244/EIJ-D-23-00624

Table 2. Operative data for 269 propensity score-matched patients treated with carotid artery stenting, according to symptomatic status at presentation: asymptomatic or symptomatic.

Asymptomatic n=224 (83.3) Symptomatic n=45 (16.7) p-value*
CAS intervention (n=269)
Predilation 25 (11.2) 3 (6.7) 0.59
Post-dilation 216 (96.4) 44 (97.8) 1
Percutaneous access site
Femoral 196 (87.5) 42 (93.3) 0.32
Radial 28 (12.5) 3 (6.7)
Cerebral protection
Proximal 142 (63.4) 32 (71.1) 0.37
Distal 82 (36.6) 13 (28.9)
Contrast medium, ml 170.3±55.9 171.3±40.8 0.92
Stents deployed 107 (47.8) 21 (46.7) 0.89
Single stent (n=1) 220 (98.2) 45 (100) 1
Multiple stents (n≥2) 4 (1.8) 0 (0)
Stent length, mm 31.6±9.2 31.3±8.4 0.86
Second-generation stents
Roadsaver 91 (40.6) 19 (42.2) 0.70
CGuard 12 (5.4) 2 (4.4)
First-generation stents
Carotid WALLSTENT 27 (12.1) 8 (17.8) 0.70
XACT 80 (35.7) 15 (33.3)
Cristallo Ideale 14 (6.3) 1 (2.2)
Debris observed in filter of the protection system (with naked eye) 7 (3.1) 1 (2.2) 1
Data are presented as mean±SD or n (%). *The chi-square test was used to evaluate qualitative distribution between the 2 groups (Fisher’s exact test if cases <5). Means were compared with the t-test. CAS: carotid artery stenting